Unsurprisingly, the stock is down 3.3% since reporting and currently trades at $9.13. Read our full report on Teladoc here, it’s free. Aiming to simplify a once complicated process, EverQuote (NASDAQ ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

Multiple reports have claimed that Apple (NASDAQ:AAPL) has been talking to JP Morgan (NYSE:JPM), the largest bank in the US, ...

Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral ...